|
1
|
Llovet JM, Zucman-Rossi J, Pikarsky E,
Sangro B, Schwartz M, Sherman M and Gores G: Hepatocellular
carcinoma. Nat Rev Dis Primers. 2:160182016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Farazi PA and DePinho RA: Hepatocellular
carcinoma pathogenesis: From genes to environment. Nat Rev Cancer.
6:674–687. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kinoshita A, Onoda H, Fushiya N, Koike K,
Nishino H and Tajiri H: Staging systems for hepatocellular
carcinoma: Current status and future perspectives. World J Hepatol.
7:406–424. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Allen MD, Luong P, Hudson C, Leyton J,
Delage B, Ghazaly E, Cutts R, Yuan M, Syed N, Lo Nigro C, et al:
Prognostic and therapeutic impact of argininosuccinate synthetase 1
control in bladder cancer as monitored longitudinally by PET
imaging. Cancer Res. 74:896–907. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhu H, Zhou X, Ma C, Chang H, Li H, Liu F
and Lu J: Low expression of miR-448 induces EMT and promotes
invasion by regulating ROCK2 in hepatocellular carcinoma. Cell
Physiol Biochem. 36:487–498. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chen W, Ye L, Wen D and Chen F: MiR-490-5p
inhibits hepatocellular carcinoma cell proliferation, migration and
invasion by directly regulating ROBO1. Pathol Oncol Res. 2:1–9.
2017.
|
|
8
|
Li Z and Wang Y: MiR-96 targets SOX6 and
promotes proliferation, migration and invasion of hepatocellular
carcinoma. Biochem Cell Biol bcb-2017-0183. 2017.
|
|
9
|
Jiang D, Cho W, Li Z, Xu X, Qu Y, Jiang Z,
Guo L and Xu G: MiR-758-3p suppresses proliferation, migration and
invasion of hepatocellular carcinoma cells via targeting MDM2 and
mTOR. Biomed Pharmacother. 96:535–544. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Li X, Song H, Liu Z and Bi Y: miR-1260b
promotes cell migration and invasion of hepatocellular carcinoma by
targeting the regulator of G-protein signaling 22. Biotechnol Lett.
40:57–62. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Imam JS, Buddavarapu K, Lee-Chang JS,
Ganapathy S, Camosy C, Chen Y and Rao MK: MicroRNA-185 suppresses
tumor growth and progression by targeting the Six1 oncogene in
human cancers. Oncogene. 29:4971–4979. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Takahashi Y, Forrest ARR, Maeno E,
Hashimoto T, Daub CO and Yasuda J: MiR-107 and MiR-185 can induce
cell cycle arrest in human non small cell lung cancer cell lines.
PLoS One. 4:e66772009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tang H, Wang Z, Liu X, Liu Q, Xu G, Li G
and Wu M: LRRC4 inhibits glioma cell growth and invasion through a
miR-185-dependent pathway. Curr Cancer Drug Targets. 12:1032–1042.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Akçakaya P, Ekelund S, Kolosenko I,
Caramuta S, Ozata DM, Xie H, Lindforss U, Olivecrona H and Lui WO:
miR-185 and miR-133b deregulation is associated with overall
survival and metastasis in colorectal cancer. Int J Oncol.
39:311–318. 2011.PubMed/NCBI
|
|
15
|
Kalender ME, Demiryürek S, Oztuzcu S,
Kizilyer A, Demiryürek AT, Sevinc A, Dikilitas M, Yildiz R and
Camci C: Association between the Thr431Asn polymorphism of the
ROCK2 gene and risk of developing metastases of breast cancer.
Oncol Res. 18:583–591. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Vigil D, Kim TY, Plachco A, Garton AJ,
Castaldo L, Pachter JA, Dong H, Chen X, Tokar B, Campbell SL, et
al: ROCK1 and ROCK2 are required for non-small cell lung cancer
anchorage-independent growth and invasion. Cancer Res.
72:5338–5347. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ma W, Sze KM, Chan LK, Lee JM, Wei LL,
Wong CM, Lee TK, Wong CC and Ng IO: RhoE/ROCK2 regulates
chemoresistance through NF-κB/IL-6/STAT3 signaling in
hepatocellular carcinoma. Oncotarget. 7:41445–41459.
2016.PubMed/NCBI
|
|
18
|
Li M, Zhou W, Yuan R, Chen L, Liu T, Huang
D, Hao L, Xie Y and Shao J: ROCK2 promotes HCC proliferation by
CEBPD inhibition through phospho-GSK3β/β-catenin signaling. FEBS
Lett. 589:1018–1025. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yao Y, Suo AL, Li ZF, Liu LY, Tian T, Ni
L, Zhang WG, Nan KJ, Song TS and Huang C: MicroRNA profiling of
human gastric cancer. Mol Med Rep. 2:963–970. 2009.PubMed/NCBI
|
|
21
|
Gottardo F, Liu CG, Ferracin M, Calin GA,
Fassan M, Bassi P, Sevignani C, Byrne D, Negrini M, Pagano F, et
al: MicroRNA profiling in kidney and bladder cancers. Urol Oncol.
25:387–392. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Liu M, Lang N, Chen X, Tang Q, Liu S,
Huang J, Zheng Y and Bi F: miR-185 targets RhoA and Cdc42
expression and inhibits the proliferation potential of human
colorectal cells. Cancer Lett. 301:151–160. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhu SM, Chen CM, Jiang ZY, Yuan B, Ji M,
Wu FH and Jin J: MicroRNA-185 inhibits cell proliferation and
epithelial-mesenchymal transition in hepatocellular carcinoma by
targeting Six2. Eur Rev Med Pharmacol Sci. 20:1712–1719.
2016.PubMed/NCBI
|
|
24
|
Zhi Q, Zhu J, Guo X, He S, Xue X, Zhou J,
Hu B, Li H, Chen S, Zhao H, et al: Metastasis-related miR-185 is a
potential prognostic biomarker for hepatocellular carcinoma in
early stage. Biomed Pharmacother. 67:393–398. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Qadir XV, Han C, Lu D, Zhang J and Wu T:
miR-185 inhibits hepatocellular carcinoma growth by targeting the
DNMT1/PTEN/Akt pathway. Am J Pathol. 184:2355–2364. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Huang D, Du X, Yuan R, Chen L, Liu T, Wen
C, Huang M, Li M, Hao L and Shao J: Rock2 promotes the invasion and
metastasis of hepatocellular carcinoma by modifying MMP2
ubiquitination and degradation. Biochem Biophys Res Commun.
453:49–56. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zheng F, Liao YJ, Cai MY, Liu YH, Liu TH,
Chen SP, Bian XW, Guan XY, Lin MC, Zeng YX, et al: The putative
tumour suppressor microRNA-124 modulates hepatocellular carcinoma
cell aggressiveness by repressing ROCK2 and EZH2. Gut. 61:278–289.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wong CC, Wong CM, Tung EK, Au SL, Lee JM,
Poon RT, Man K and Ng IO: The microRNA miR-139 suppresses
metastasis and progression of hepatocellular carcinoma by
down-regulating Rho-kinase 2. Gastroenterology. 140:322–331. 2011.
View Article : Google Scholar : PubMed/NCBI
|
